The New Jersey Supreme Court has granted a motion filed by McCarter lawyers Thomas Doherty, Ilana Levin, and David Kott for leave that the New Jersey Business and Industry Association appear as an amicus curiae and present oral argument in an employment law case. Tom will present oral argument that Continue Reading
Ex-Philly Union Head Faces Long Odds in 3rd Corruption Trial
A former Philadelphia labor leader who has now been convicted twice for embezzlement and bribery is now facing a third trial. Former federal prosecutor and Chair of McCarter’s Government Investigations & White Collar Defense group Robert Mintz spoke with Law360 about the challenges facing Continue Reading
FDA Approves First Crispr Gene Therapy, Affordability Questions Remain
The Food and Drug Administration approved for the first time a CRISPR-based genetic therapy, the sickle cell treatment exagamglogene autotemcel (exa-cel). While questions remain about how payers will cover the cost of the therapies, a complex patent dispute may also result in potential delays for Continue Reading
First-Ever CRISPR Drug, Made by Two Boston Companies, Is Approved in the US
The Food and Drug Administration has granted approval to exa-cel, a drug made by Vertex Pharmaceuticals Inc. and CRISPR Therapeutics Inc. to be marketed under the name Casgevy. Maria Laccotripe Zacharakis spoke with the Boston Business Journal about a potential intellectual property dispute over the Continue Reading
Meet McCarter & English’s First Gov’t Affairs Hire In Conn.
Vin Mauro is moving into private practice and is set to join McCarter & English’s Government Affairs Practice Group after nearly three decades with the Connecticut Senate Democrats. In an interview with Law360 Pulse, Vin spoke about his interest in government and how the transition into Continue Reading
McCarter Partner Joe Braunreuther Joins FedArb As Mediator
Joe Braunreuther joined FedArb’s panel of mediators. FedArb is a nationwide alternative dispute resolution firmAs a panelist, Braunreuther will serve as a mediator and special master, focused on resolving business/ commercial, class actions, intellectual property, pharmaceutical, product liability, Continue Reading
What Evidence Will be Allowed in the Election Interference Case Against Former President Trump?
As the election interference case against former President Trump heads to trial, the defense team is seeking to block prosecutors from presenting evidence of January 6th violence. Former federal prosecutor and chair of McCarter's White Collar Defense and Government Investigations group, Robert Continue Reading
Michael Maitland Named a 2023 Top Lobbyist by The Hill
For the second year in a row, Government Affairs Advisor Michael Maitland was named a Top Lobbyist of 2023 by The Hill. The Top Lobbyist List recognizes government affairs professionals who utilized their expertise and network to facilitate change in the nation’s capital. Continue Reading
Hiring Gets New Scrutiny in NLRB Mozilla Complaint
A recent complaint from the National Labor Relations Board (NLRB) is accusing Mozilla of violating federal labor law by refusing to hire a programmer for a job as a software engineer because of online discussions she led about her job search. Hugh Murray spoke with Law360 and said that the new Continue Reading
McCarter & English Strengthens Its Intellectual Property Transaction Capabilities with the Addition of Jeffrey Mann in Its New York Office
McCarter & English has announced the addition of Jeffrey M. Mann as a partner in its Intellectual Property Practice Group in New York. Mann will utilize his two decades of experience across multiple disciplines in intellectual property law to help clients structure strategic transactions, Continue Reading